Curaleaf Holdings, Inc.: CEO compensation changes

What happened The filing reports that on Sep 28, 2026 the Compensation Committee and the Board approved certain compensation arrangements for Curaleaf’s chairman and chief executive officer, Boris Jordan. The Committee and the Board increased Mr. Jordan’s target 2027 short-term incentive opportunity, awarded a discretionary target bonus opportunity, and approved a one-time grant of restricted stock units.

Key details

• increased Mr. Jordan’s target 2027 short-term incentive from 125% of his 2027 base salary to 200% of his base salary.
• awarded a discretionary target bonus of $1,000,000 for achievement of certain strategic targets, with any award amount to be determined in Mar 2028.
• approved a one-time grant of 1,344,275 time-based restricted stock units with a grant date fair value of $15,448,435 that will vest in full on Jan 5, 2028.
• the RSU grant was made pursuant to Curaleaf’s 2018 Stock and Incentive Plan and the form of Restricted Unit Award Agreement approved thereunder; the report was signed Oct 2, 2026 by Peter Clateman, chief legal officer.

Why it may matter The filing is reported under Item 5.02 (departure of directors or certain officers; election of directors), which covers changes involving officers or directors; here the filing reports compensation arrangements approved for the company’s chairman and chief executive officer. The filing does not show why the insider traded or why the company acted.